France's largest pharmaceutical company went on trial Monday on suspicion that their weight-loss drug has caused up to 2,000 deaths and lifelong consequences for many other patients, the Guardian reported.
We use cookies to improve your experience on our website. Find out more or opt out Accept
And get our latest investigations on organized crime and corruption delivered straight to your inbox.